静脈内輸液ポンプ市場：製品別、適応疾患別-2025-2030年の世界予測

静脈内輸液ポンプ市場は、2023年に44億4,000万米ドルと評価され、2024年には48億5,000万米ドルに達すると予測され、CAGR 9.85%で成長し、2030年には85億7,000万米ドルに達すると予測されています。

静脈内（IV）注入ポンプは、栄養剤や薬剤などの液体を、制御された量で患者の血流に直接送り込むために設計された重要な医療機器です。その必要性は、最適な治療結果と患者の安全性を確保するため、特に重症患者を対象とした医療現場では、輸液を正確に投与する必要があることから生じています。病院、外来診療所、在宅医療などのヘルスケア施設で広く使用されています。最終用途の範囲は、正確な輸液管理が重要な腫瘍学、消化器病学、小児科、疼痛管理など、多様な医療領域にわたっています。慢性疾患の有病率の増加、老人人口の増加、ヘルスケア機器の技術進歩は、輸液ポンプ市場を牽引する主要な成長要因です。この市場における最新の潜在的機会は、クラウドコンピューティングやIoTなどのスマート技術の統合にあり、これによりデータ分析や遠隔モニタリング機能の強化が可能になります。こうした機会を捉えるために、企業はハイテク企業との共同イノベーションに注力し、研究開発努力を拡大し、規制コンプライアンスを強化すべきです。しかし、高度なポンプの高コスト、厳しい規制要件、技術的誤作動のリスクなどの制約が、市場成長にとって大きな課題となっています。さらに、これらの機器を操作し患者の安全を確保するためには、訓練を受けたヘルスケア専門家が必要であることも、市場拡大の妨げになる可能性があります。技術革新が必要な分野としては、高度な安全機能を備えたコスト効率の高い輸液ポンプの開発、無線通信機能の向上、ヒューマンエラーを減らすためのユーザーインターフェイス設計の強化などが挙げられます。また、機能を損なうことなく携帯性を高めるための装置小型化の調査も、市場の成長を促進する可能性があります。輸液ポンプ市場は競争市場であり、継続的な技術の進歩と厳しい規制の枠組みによって特徴付けられ、進化するヘルスケア標準と需要に対応するために絶え間ない技術革新が必要です。技術の統合とコンプライアンスに向けた積極的なアプローチを採用することは、持続的な成長を目指す企業にとって極めて重要です。

市場力学：急速に進化する静脈内輸液ポンプ市場の主要市場インサイトを公開

静脈内輸液ポンプ市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的意思決定、新たなビジネスチャンスの獲得を行うことができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 老年人口に伴う慢性疾患の罹患率の増加
  • 外科手術を受ける人の増加
  • 外来用輸液ポンプの需要増加
• 市場抑制要因
  • 輸液ポンプに対する患者の安全リスクと投薬ミス
• 市場機会
  • 特殊輸液ポンプの採用拡大
  • 輸液ポンプの技術的進歩
• 市場の課題
  • 再生輸液ポンプの採用増加

ポーターの5つの力：静脈内輸液ポンプ市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：静脈内輸液ポンプ市場における外部からの影響の把握

外部マクロ環境要因は、静脈内輸液ポンプ市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析静脈内輸液ポンプ市場における競合情勢の把握

静脈内輸液ポンプ市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス静脈内輸液ポンプ市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、静脈内輸液ポンプ市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨静脈内輸液ポンプ市場における成功への道筋を描く

静脈内輸液ポンプ市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 高齢化に伴い慢性疾患の発生率も増加
    • 外科手術を受ける人の数の増加
    • 外来輸液ポンプの需要増加
  • 抑制要因
    • 輸液ポンプの患者安全リスクと投薬ミス
  • 機会
    • 特殊輸液ポンプの採用増加
    • 輸液ポンプの技術的進歩
  • 課題
    • 再生輸液ポンプの採用増加
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 静脈内輸液ポンプ市場：製品別

• 携帯型輸液ポンプ
• 経腸輸液ポンプ
• 埋め込み型輸液ポンプ
• インスリン注入ポンプ
• 患者自己管理鎮痛輸液ポンプ
• シリンジ輸液ポンプ
• 容積式輸液ポンプ

第7章 静脈内輸液ポンプ市場：疾患適応症別

• 鎮痛または疼痛管理
• 化学療法
• 糖尿病
• 消化器内科
• 血液学
• 小児科・新生児科

第8章 南北アメリカの静脈内輸液ポンプ市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第9章 アジア太平洋地域の静脈内輸液ポンプ市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第10章 欧州・中東・アフリカの静脈内輸液ポンプ市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第11章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• Adepto Medical
• ANGEL Electronics
• B. Braun Melsungen AG
• Baxter International
• Becton, Dickinson and Company
• Boston Scientific corporation
• Carefusion Corporation
• CODAN ARGUS AG
• F. Hoffmann La Roche Ltd.
• Fresenius SE & Co.
• Ivenix Inc.
• J2S Medical
• Medtronic Plc.
• Micrel Medical Devices Sa
• Pfizer Inc.
• Shenzhen Hawk Medical Instrument Co. Ltd.
• Smiths Medical Plc.
• Terumo Corporation
• Venner Medical
• ZOLL Medical Corporation

LIST OF FIGURES

• FIGURE 1. INTRAVENOUS INFUSION PUMP MARKET RESEARCH PROCESS
• FIGURE 2. INTRAVENOUS INFUSION PUMP MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL INTRAVENOUS INFUSION PUMP MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL INTRAVENOUS INFUSION PUMP MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL INTRAVENOUS INFUSION PUMP MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL INTRAVENOUS INFUSION PUMP MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL INTRAVENOUS INFUSION PUMP MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL INTRAVENOUS INFUSION PUMP MARKET SIZE, BY DISEASE INDICATION, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL INTRAVENOUS INFUSION PUMP MARKET SIZE, BY DISEASE INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. AMERICAS INTRAVENOUS INFUSION PUMP MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 11. AMERICAS INTRAVENOUS INFUSION PUMP MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. UNITED STATES INTRAVENOUS INFUSION PUMP MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 13. UNITED STATES INTRAVENOUS INFUSION PUMP MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. ASIA-PACIFIC INTRAVENOUS INFUSION PUMP MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 15. ASIA-PACIFIC INTRAVENOUS INFUSION PUMP MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS INFUSION PUMP MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS INFUSION PUMP MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. INTRAVENOUS INFUSION PUMP MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 19. INTRAVENOUS INFUSION PUMP MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. INTRAVENOUS INFUSION PUMP MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL INTRAVENOUS INFUSION PUMP MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL INTRAVENOUS INFUSION PUMP MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL INTRAVENOUS INFUSION PUMP MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. INTRAVENOUS INFUSION PUMP MARKET DYNAMICS
• TABLE 7. GLOBAL INTRAVENOUS INFUSION PUMP MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL INTRAVENOUS INFUSION PUMP MARKET SIZE, BY AMBULATORY INFUSION PUMPS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL INTRAVENOUS INFUSION PUMP MARKET SIZE, BY ENTERAL INFUSION PUMPS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL INTRAVENOUS INFUSION PUMP MARKET SIZE, BY IMPLANTABLE INFUSION PUMPS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL INTRAVENOUS INFUSION PUMP MARKET SIZE, BY INSULIN INFUSION PUMPS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL INTRAVENOUS INFUSION PUMP MARKET SIZE, BY PATIENT-CONTROLLED ANALGESIA INFUSION PUMPS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL INTRAVENOUS INFUSION PUMP MARKET SIZE, BY SYRINGE INFUSION PUMPS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL INTRAVENOUS INFUSION PUMP MARKET SIZE, BY VOLUMETRIC INFUSION PUMPS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL INTRAVENOUS INFUSION PUMP MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL INTRAVENOUS INFUSION PUMP MARKET SIZE, BY ANALGESIA OR PAIN MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL INTRAVENOUS INFUSION PUMP MARKET SIZE, BY CHEMOTHERAPY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL INTRAVENOUS INFUSION PUMP MARKET SIZE, BY DIABETES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL INTRAVENOUS INFUSION PUMP MARKET SIZE, BY GASTROENTEROLOGY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL INTRAVENOUS INFUSION PUMP MARKET SIZE, BY HEMATOLOGY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL INTRAVENOUS INFUSION PUMP MARKET SIZE, BY PEDIATRICS & NEONATOLOGY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. AMERICAS INTRAVENOUS INFUSION PUMP MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 23. AMERICAS INTRAVENOUS INFUSION PUMP MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
• TABLE 24. AMERICAS INTRAVENOUS INFUSION PUMP MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 25. ARGENTINA INTRAVENOUS INFUSION PUMP MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 26. ARGENTINA INTRAVENOUS INFUSION PUMP MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
• TABLE 27. BRAZIL INTRAVENOUS INFUSION PUMP MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 28. BRAZIL INTRAVENOUS INFUSION PUMP MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
• TABLE 29. CANADA INTRAVENOUS INFUSION PUMP MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 30. CANADA INTRAVENOUS INFUSION PUMP MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
• TABLE 31. MEXICO INTRAVENOUS INFUSION PUMP MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 32. MEXICO INTRAVENOUS INFUSION PUMP MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
• TABLE 33. UNITED STATES INTRAVENOUS INFUSION PUMP MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 34. UNITED STATES INTRAVENOUS INFUSION PUMP MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
• TABLE 35. UNITED STATES INTRAVENOUS INFUSION PUMP MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 36. ASIA-PACIFIC INTRAVENOUS INFUSION PUMP MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 37. ASIA-PACIFIC INTRAVENOUS INFUSION PUMP MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
• TABLE 38. ASIA-PACIFIC INTRAVENOUS INFUSION PUMP MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 39. AUSTRALIA INTRAVENOUS INFUSION PUMP MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 40. AUSTRALIA INTRAVENOUS INFUSION PUMP MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
• TABLE 41. CHINA INTRAVENOUS INFUSION PUMP MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 42. CHINA INTRAVENOUS INFUSION PUMP MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
• TABLE 43. INDIA INTRAVENOUS INFUSION PUMP MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 44. INDIA INTRAVENOUS INFUSION PUMP MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
• TABLE 45. INDONESIA INTRAVENOUS INFUSION PUMP MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 46. INDONESIA INTRAVENOUS INFUSION PUMP MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
• TABLE 47. JAPAN INTRAVENOUS INFUSION PUMP MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 48. JAPAN INTRAVENOUS INFUSION PUMP MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
• TABLE 49. MALAYSIA INTRAVENOUS INFUSION PUMP MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 50. MALAYSIA INTRAVENOUS INFUSION PUMP MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
• TABLE 51. PHILIPPINES INTRAVENOUS INFUSION PUMP MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 52. PHILIPPINES INTRAVENOUS INFUSION PUMP MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
• TABLE 53. SINGAPORE INTRAVENOUS INFUSION PUMP MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 54. SINGAPORE INTRAVENOUS INFUSION PUMP MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
• TABLE 55. SOUTH KOREA INTRAVENOUS INFUSION PUMP MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 56. SOUTH KOREA INTRAVENOUS INFUSION PUMP MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
• TABLE 57. TAIWAN INTRAVENOUS INFUSION PUMP MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 58. TAIWAN INTRAVENOUS INFUSION PUMP MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
• TABLE 59. THAILAND INTRAVENOUS INFUSION PUMP MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 60. THAILAND INTRAVENOUS INFUSION PUMP MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
• TABLE 61. VIETNAM INTRAVENOUS INFUSION PUMP MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 62. VIETNAM INTRAVENOUS INFUSION PUMP MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
• TABLE 63. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS INFUSION PUMP MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 64. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS INFUSION PUMP MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
• TABLE 65. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS INFUSION PUMP MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 66. DENMARK INTRAVENOUS INFUSION PUMP MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 67. DENMARK INTRAVENOUS INFUSION PUMP MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
• TABLE 68. EGYPT INTRAVENOUS INFUSION PUMP MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 69. EGYPT INTRAVENOUS INFUSION PUMP MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
• TABLE 70. FINLAND INTRAVENOUS INFUSION PUMP MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 71. FINLAND INTRAVENOUS INFUSION PUMP MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
• TABLE 72. FRANCE INTRAVENOUS INFUSION PUMP MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 73. FRANCE INTRAVENOUS INFUSION PUMP MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
• TABLE 74. GERMANY INTRAVENOUS INFUSION PUMP MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 75. GERMANY INTRAVENOUS INFUSION PUMP MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
• TABLE 76. ISRAEL INTRAVENOUS INFUSION PUMP MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 77. ISRAEL INTRAVENOUS INFUSION PUMP MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
• TABLE 78. ITALY INTRAVENOUS INFUSION PUMP MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 79. ITALY INTRAVENOUS INFUSION PUMP MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
• TABLE 80. NETHERLANDS INTRAVENOUS INFUSION PUMP MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 81. NETHERLANDS INTRAVENOUS INFUSION PUMP MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
• TABLE 82. NIGERIA INTRAVENOUS INFUSION PUMP MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 83. NIGERIA INTRAVENOUS INFUSION PUMP MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
• TABLE 84. NORWAY INTRAVENOUS INFUSION PUMP MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 85. NORWAY INTRAVENOUS INFUSION PUMP MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
• TABLE 86. POLAND INTRAVENOUS INFUSION PUMP MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 87. POLAND INTRAVENOUS INFUSION PUMP MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
• TABLE 88. QATAR INTRAVENOUS INFUSION PUMP MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 89. QATAR INTRAVENOUS INFUSION PUMP MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
• TABLE 90. RUSSIA INTRAVENOUS INFUSION PUMP MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 91. RUSSIA INTRAVENOUS INFUSION PUMP MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
• TABLE 92. SAUDI ARABIA INTRAVENOUS INFUSION PUMP MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 93. SAUDI ARABIA INTRAVENOUS INFUSION PUMP MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
• TABLE 94. SOUTH AFRICA INTRAVENOUS INFUSION PUMP MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 95. SOUTH AFRICA INTRAVENOUS INFUSION PUMP MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
• TABLE 96. SPAIN INTRAVENOUS INFUSION PUMP MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 97. SPAIN INTRAVENOUS INFUSION PUMP MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
• TABLE 98. SWEDEN INTRAVENOUS INFUSION PUMP MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 99. SWEDEN INTRAVENOUS INFUSION PUMP MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
• TABLE 100. SWITZERLAND INTRAVENOUS INFUSION PUMP MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 101. SWITZERLAND INTRAVENOUS INFUSION PUMP MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
• TABLE 102. TURKEY INTRAVENOUS INFUSION PUMP MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 103. TURKEY INTRAVENOUS INFUSION PUMP MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
• TABLE 104. UNITED ARAB EMIRATES INTRAVENOUS INFUSION PUMP MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 105. UNITED ARAB EMIRATES INTRAVENOUS INFUSION PUMP MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
• TABLE 106. UNITED KINGDOM INTRAVENOUS INFUSION PUMP MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 107. UNITED KINGDOM INTRAVENOUS INFUSION PUMP MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
• TABLE 108. INTRAVENOUS INFUSION PUMP MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 109. INTRAVENOUS INFUSION PUMP MARKET, FPNV POSITIONING MATRIX, 2023

The Intravenous Infusion Pump Market was valued at USD 4.44 billion in 2023, expected to reach USD 4.85 billion in 2024, and is projected to grow at a CAGR of 9.85%, to USD 8.57 billion by 2030.

Intravenous (IV) infusion pumps are critical medical devices designed to deliver fluids, such as nutrients and medications, directly into a patient's bloodstream in controlled amounts. Their necessity arises from the need for precise administration of fluids, especially in critical care settings, to ensure optimal therapeutic outcomes and patient safety. They are widely used in healthcare facilities including hospitals, outpatient clinics, and home healthcare settings. The end-use scope spans across diverse medical domains, including oncology, gastroenterology, pediatrics, and pain management, where precise fluid administration is crucial. The growing prevalence of chronic diseases, increasing geriatric population, and technological advancements in healthcare devices are key growth factors driving the IV infusion pumps market. The latest potential opportunities in this market lie in the integration of smart technologies such as cloud computing and IoT, which enable enhanced data analytics and remote monitoring capabilities. To seize these opportunities, companies should focus on collaborative innovations with tech firms, expand R&D efforts, and enhance regulatory compliance. However, limitations such as high costs of advanced pumps, stringent regulatory requirements, and risks of technical malfunctions pose significant challenges to market growth. Additionally, the need for trained healthcare professionals to operate these devices and ensure patient safety may impede market expansion. Areas ripe for innovation include developing cost-effective infusion pumps equipped with advanced safety features, improving wireless communication capabilities, and enhancing user interface designs to reduce human error. Research into reducing device size for portability without compromising functionality could also drive market growth. The IV infusion pump market is competitive, characterized by continuous technological advancements and rigorous regulatory frameworks that necessitate constant innovation to meet evolving healthcare standards and demands. Adopting a proactive approach towards technology integration and compliance will be crucial for businesses aiming to achieve sustainable growth.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Intravenous Infusion Pump Market

The Intravenous Infusion Pump Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increasing incidence of chronic diseases along with geriatric population
  • Rising number of people undergoing surgical procedures
  • Increasing demand for ambulatory infusion pumps
• Market Restraints
  • Patient safety risk and medication errors to infusion pumps
• Market Opportunities
  • Growing adoption of specialty infusion pumps
  • Technological advancements in infusion pumps
• Market Challenges
  • Increasing adoption of refurbished infusion pumps

Porter's Five Forces: A Strategic Tool for Navigating the Intravenous Infusion Pump Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Intravenous Infusion Pump Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Intravenous Infusion Pump Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Intravenous Infusion Pump Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Intravenous Infusion Pump Market

A detailed market share analysis in the Intravenous Infusion Pump Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Intravenous Infusion Pump Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Intravenous Infusion Pump Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Intravenous Infusion Pump Market

A strategic analysis of the Intravenous Infusion Pump Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Intravenous Infusion Pump Market, highlighting leading vendors and their innovative profiles. These include Adepto Medical, ANGEL Electronics, B. Braun Melsungen AG, Baxter International, Becton, Dickinson and Company, Boston Scientific corporation, Carefusion Corporation, CODAN ARGUS AG, F. Hoffmann La Roche Ltd., Fresenius SE & Co., Ivenix Inc., J2S Medical, Medtronic Plc., Micrel Medical Devices Sa, Pfizer Inc., Shenzhen Hawk Medical Instrument Co. Ltd., Smiths Medical Plc., Terumo Corporation, Venner Medical, and ZOLL Medical Corporation.

Market Segmentation & Coverage

This research report categorizes the Intravenous Infusion Pump Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product, market is studied across Ambulatory Infusion Pumps, Enteral Infusion Pumps, Implantable Infusion Pumps, Insulin Infusion Pumps, Patient-Controlled Analgesia Infusion Pumps, Syringe Infusion Pumps, and Volumetric Infusion Pumps.
• Based on Disease Indication, market is studied across Analgesia or Pain Management, Chemotherapy, Diabetes, Gastroenterology, Hematology, and Pediatrics & Neonatology.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing incidence of chronic diseases along with geriatric population
    • 5.1.1.2. Rising number of people undergoing surgical procedures
    • 5.1.1.3. Increasing demand for ambulatory infusion pumps
  • 5.1.2. Restraints
    • 5.1.2.1. Patient safety risk and medication errors to infusion pumps
  • 5.1.3. Opportunities
    • 5.1.3.1. Growing adoption of specialty infusion pumps
    • 5.1.3.2. Technological advancements in infusion pumps
  • 5.1.4. Challenges
    • 5.1.4.1. Increasing adoption of refurbished infusion pumps
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Intravenous Infusion Pump Market, by Product

• 6.1. Introduction
• 6.2. Ambulatory Infusion Pumps
• 6.3. Enteral Infusion Pumps
• 6.4. Implantable Infusion Pumps
• 6.5. Insulin Infusion Pumps
• 6.6. Patient-Controlled Analgesia Infusion Pumps
• 6.7. Syringe Infusion Pumps
• 6.8. Volumetric Infusion Pumps

7. Intravenous Infusion Pump Market, by Disease Indication

• 7.1. Introduction
• 7.2. Analgesia or Pain Management
• 7.3. Chemotherapy
• 7.4. Diabetes
• 7.5. Gastroenterology
• 7.6. Hematology
• 7.7. Pediatrics & Neonatology

8. Americas Intravenous Infusion Pump Market

• 8.1. Introduction
• 8.2. Argentina
• 8.3. Brazil
• 8.4. Canada
• 8.5. Mexico
• 8.6. United States

9. Asia-Pacific Intravenous Infusion Pump Market

• 9.1. Introduction
• 9.2. Australia
• 9.3. China
• 9.4. India
• 9.5. Indonesia
• 9.6. Japan
• 9.7. Malaysia
• 9.8. Philippines
• 9.9. Singapore
• 9.10. South Korea
• 9.11. Taiwan
• 9.12. Thailand
• 9.13. Vietnam

10. Europe, Middle East & Africa Intravenous Infusion Pump Market

• 10.1. Introduction
• 10.2. Denmark
• 10.3. Egypt
• 10.4. Finland
• 10.5. France
• 10.6. Germany
• 10.7. Israel
• 10.8. Italy
• 10.9. Netherlands
• 10.10. Nigeria
• 10.11. Norway
• 10.12. Poland
• 10.13. Qatar
• 10.14. Russia
• 10.15. Saudi Arabia
• 10.16. South Africa
• 10.17. Spain
• 10.18. Sweden
• 10.19. Switzerland
• 10.20. Turkey
• 10.21. United Arab Emirates
• 10.22. United Kingdom

11. Competitive Landscape

• 11.1. Market Share Analysis, 2023
• 11.2. FPNV Positioning Matrix, 2023
• 11.3. Competitive Scenario Analysis
• 11.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Adepto Medical
• 2. ANGEL Electronics
• 3. B. Braun Melsungen AG
• 4. Baxter International
• 5. Becton, Dickinson and Company
• 6. Boston Scientific corporation
• 7. Carefusion Corporation
• 8. CODAN ARGUS AG
• 9. F. Hoffmann La Roche Ltd.
• 10. Fresenius SE & Co.
• 11. Ivenix Inc.
• 12. J2S Medical
• 13. Medtronic Plc.
• 14. Micrel Medical Devices Sa
• 15. Pfizer Inc.
• 16. Shenzhen Hawk Medical Instrument Co. Ltd.
• 17. Smiths Medical Plc.
• 18. Terumo Corporation
• 19. Venner Medical
• 20. ZOLL Medical Corporation